ARCHIVES

NCI/NTP Studies Found EDB Carcinogenic, But Risk To Human Said Not Conclusive

This article is from The Cancer Letter archive.

Vol. 10 No. 12 | March 23, 1984

Download PDF Visit The Full Archive

Related Articles

AACR thanks NCI for funds, provides platform for von Eschenbach’s 2015 goal. Also 2015 goal not a dream, but a vision, NCI director says.

July 18, 2003

About Face; NCI To Keep Preclinical AIDS Drug Development

December 12, 1986

NSABP Researcher Committed Misconduct, NIH Investigation Finds

March 18, 1994

Survival Benefit For Vinorelbine-Cisplatin In NSCLC Patient, Phase III Trial Finds

August 26, 2005

CAB Reluctantly Approves Use Of Contract To Support Cancer Journals

February 15, 1985

NIH Scientists Engineer Mice That Get Burkitt’s Lymphoma.

October 20, 2000